Canine Cancer Immunotherapy Network (K9CIN)
Funds a five-award network running canine cancer immunotherapy trials whose results are meant to translate directly into human cancer treatment.
Testing a cancer therapy on healthy lab animals tells you less than testing it on an animal that developed cancer on its own. Pet dogs do that, and their disease behaves enough like human cancer that treating them can double as an early, honest test of what might work in people.
This funds a five-award network built around exactly that idea. One award creates a Network Coordinating Center, which …
A five-award cooperative-agreement network for canine cancer immunotherapy: one Network Coordinating Center plus four sites running clinical trials of immunotherapeutic agents, alone or combined with other treatments, in pet dogs with spontaneous cancer as a translational model for human cancer therapy.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up